SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-24-084334
Filing Date
2024-07-31
Accepted
2024-07-31 16:05:21
Documents
1
Period of Report
2024-04-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2420560-1_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2420560-1_4aseq1.xml 4/A 7202
  Complete submission text file 0001104659-24-084334.txt   9003
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address
Lebovits Chaim (Reporting) CIK: 0001406302 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36641 | Film No.: 241161887